Figure 2.
The comparative cytolytic efficacy of the fiber-modified replication-competent recombinant adenoviruses in human primary short-term glioma (n = 8) and medulloblastoma (n = 1, MB-TSCH) cultures
(A–I) Resazurin/Alamar Blue cell viability assays of rAd-infected short-term glioma cell cultures 7 days post-infection (except GliBah, 6 days post-infection). The glioma cultures (5 × 103 cells/well) were infected in suspension with a serial 10-fold dilution of the indicated rAds starting from 1,000 vp/cell. Normalized data are presented as the mean ± SD of two independent experiments in technical triplicates. See also Figure S5.